A retrospective study assessing the efficacy of a regimen consisting of Rituximab and Emicizumab in patients with acquired Hemophilia A
Latest Information Update: 06 Feb 2023
At a glance
- Drugs Emicizumab (Primary) ; Ruxolitinib (Primary) ; Prednisone
- Indications Haemophilia A
- Focus Therapeutic Use
- 01 Jan 2023 Results published in the Haemophilia
- 12 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology